Bruker Corporation

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
82.94 ^USD	-1.13%		-6.31%	+12.87%

Apr. 10	Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating	MT
Apr. 08	Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	CI

Bruker Corporation(NasdaqGS:BRKR) added to S&P 400 Health Care

December 02, 2021 at 12:00 am EST

Bruker Corporation(NasdaqGS:BRKR) added to S&P 400 Health Care (Sector)

Latest news about Bruker Corporation

Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating	Apr. 10	MT
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	Apr. 08	CI
Bruker Corporation Enters into Term Loan Agreement with Bank of America, N.A	Apr. 02	CI
Bruker Corporation Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO	Mar. 11	CI
Bruker Corporation completed the acquisition of Chemspeed Technologies AG.	Mar. 06	CI
Transcript : Bruker Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09:50 AM	Mar. 04
UBS Raises Bruker Price Target to $102 From $94, Maintains Buy Rating	Mar. 01	MT
Transcript : Bruker Corporation Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 08:45 AM	Feb. 29
Bruker to Acquire ELITechGroup for About $943 Million in Cash	Feb. 28	MT
Bruker Corporation entered into an agreement to acquire ELITech Group SAS from Tecfin S.À R.L. for approximately ?870 million.	Feb. 27	CI
Bruker Insider Sold Shares Worth $1,276,073, According to a Recent SEC Filing	Feb. 26	MT
Bruker Keeps Quarterly Dividend at $0.05 Per Share, Payable March 15 to Shareholders of Record on March 1	Feb. 16	MT
Bruker Corporation Approves Payment of A Quarterly Cash Dividend, Payable on March 15, 2024	Feb. 16	CI
UBS Adjusts Bruker Price Target to $94 From $86, Maintains Buy Rating	Feb. 15	MT
TD Cowen Adjusts Bruker's Price Target to $84 From $75, Keeps Market Perform Rating	Feb. 14	MT
Stifel Adjusts Bruker's Price Target to $81 From $63, Keeps Hold Rating	Feb. 14	MT
Leerink Partners Adjusts Bruker's Price Target to $90 From $86, Keeps Outperform Rating	Feb. 14	MT
Citigroup Adjusts Bruker's Price Target to $95 From $80, Keeps Buy Rating	Feb. 14	MT
Jefferies Adjusts Bruker's Price Target to $90 From $72, Keeps Buy Rating	Feb. 14	MT
Goldman Sachs Adjusts Bruker's Price Target to $66 From $58, Keeps Sell Rating	Feb. 14	MT
JPMorgan Upgrades Bruker to Overweight From Neutral, Adjusts Price Target to $90 From $60	Feb. 14	MT
Bruker Shares Rise Following Q4 Beat	Feb. 13	MT
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	Feb. 13	MT
Bruker's Q4 Earnings Decline, Revenue Rises; Provides 2024 Guidance; Shares Gain 5% Pre-Bell	Feb. 13	MT
Transcript : Bruker Corporation, Q4 2023 Earnings Call, Feb 13, 2024	Feb. 13

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Companyâs BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It offers scanning transmission electron microscopes (STEM). It also offers advanced research Raman microscopy systems.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-01 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Bruker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

82.94 USD

Average target price

88.7 USD

Spread / Average Target

+6.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BRUKER CORPORATION	+12.87%	11.42B
THERMO FISHER SCIENTIFIC	+3.10%	209B
DANAHER CORPORATION	+3.48%	177B
INTUITIVE SURGICAL, INC.	+10.91%	133B
BOSTON SCIENTIFIC CORPORATION	+17.56%	99.89B
SIEMENS HEALTHINEERS AG	-0.99%	61.83B
EDWARDS LIFESCIENCES CORPORATION	+14.41%	52.51B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.21%	45.54B
AGILENT TECHNOLOGIES, INC.	-3.22%	39.43B
GE HEALTHCARE TECHNOLOGIES INC.	+10.18%	38.87B

Other Advanced Medical Equipment & Technology